Home/Filings/4/0001209191-23-044035
4//SEC Filing

Fuhrman Alan 4

Accession 0001209191-23-044035

CIK 0001863127other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 5:34 PM ET

Size

5.4 KB

Accession

0001209191-23-044035

Insider Transaction Report

Form 4
Period: 2023-07-28
Fuhrman Alan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-28+62,68562,685 total
    Exercise: $14.35Exp: 2033-07-27Common Stock (62,685 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option will vest on July 28, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001303521

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:34 PM ET
Size
5.4 KB